Skip to main content
SpringerLink
Log in

Drugs-of-Abuse Testing in Saliva or Oral Fluid

  • Chapter
Drug Testing in Alternate Biological Specimens

Part of the book series: Forensic Science And Medicine ((FSM))

  • 1416 Accesses

Summary

Historically, saliva or oral fluid has been tested for monitoring therapeutic drugs. Drugs-of-abuse, including cannabinoids, opioids, amphetamines, and cocaine, have been detected in this matrix. Multiple collection procedures and devices are available. The route of administration, collection procedures, and saliva : plasma ratios affect the amount of drug deposited. However, current analytical techniques may be utilized for testing provided the relevant compound is targeted. The window of detection is comparable to blood and is therefore conducive to detecting recent drug use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dvorchik B and Vessell E. Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin. Chem. 22(6):868–878; 1976.

    PubMed  CAS  Google Scholar 

  2. Peel HW, Perrigo BJ and Mikhael NZ. Detection of drugs in saliva of impaired drivers. J. Forensic Sci. 29(1):185–189; 1984.

    PubMed  CAS  Google Scholar 

  3. Toennes S, Steinmeyer S, Maurer H, Moeller M and Kauert G. Screening for drugs of abuse in oral fluid–correlation of analysis results with serum in forensic cases. J. Anal. Toxicol. 29(1):22–27; 2005.

    PubMed  CAS  Google Scholar 

  4. Biermann T, Schwarze B, Zedler B and Betz P. On-site testing of illicit drugs: the use of the drug-testing device “Toxiquick.” Forensic Sci. Int. 143(1):21–25; 2004.

    Article  PubMed  CAS  Google Scholar 

  5. Samyn N, De Boeck G and Verstraete A. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J. Forensic Sci. 47(6):1380–1387; 2002.

    PubMed  CAS  Google Scholar 

  6. Steinmeyer S, Ohr H, Maurer H and Moeller M. Practical aspects of roadside tests for administrative traffic offences in Germany. Forensic Sci. Int. 121(1–2):33–36; 2001.

    Article  PubMed  CAS  Google Scholar 

  7. Kintz P, Crimele V and Ludes B. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J. Anal. Toxicol. 24:557–561; 2000.

    PubMed  CAS  Google Scholar 

  8. Idowu O and Caddy B. A review of the use of saliva in the forensic detection of drugs and other chemicals. J. Forensic Sci. Soc. 22:123–135; 1982.

    Article  PubMed  CAS  Google Scholar 

  9. Yacoubian G, Wish E and Perez D. A comparison of saliva testing to urinalysis in an arrestee population. J. Psychoactive Drugs 33(3):289–294; 2001.

    PubMed  Google Scholar 

  10. Schramm W, Smith R, Craig P and Kidwell D. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16:1–9; 1992.

    PubMed  CAS  Google Scholar 

  11. Cooper G, Wilson L, Reid C, Main L and Hand C. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid. Forensic Sci. Int. 150:239–243; 2005.

    Article  PubMed  CAS  Google Scholar 

  12. Dawes C and Jenkins G. The effects of different stimuli on the composition of saliva in man. J. Physiol. 170:86–100; 1964.

    PubMed  CAS  Google Scholar 

  13. Malamud D. Guidelines for saliva nomenclature and collection. Ann. N. Y. Acad. Sci. 694:xi–xii; 1993.

    Article  Google Scholar 

  14. Haeckel R and Hanecke P. Application of saliva for drug monitoring an in vivo model for transmembrane transport. Eur. J. Clin. Chem. Biochem. 34:171–191; 1996.

    CAS  Google Scholar 

  15. Jenkins A, Oyler J and Cone E. Comparison of heroin and cocaine concentration in saliva with concentrations in blood and plasma. J. Anal. Toxicol. 19:359–374; 1995.

    PubMed  CAS  Google Scholar 

  16. Jenkins A, Keenan R, Jenningfield J and Cone E. Pharmacokinetics and pharmacodynamics of smoked heroin. J. Anal. Toxicol. 18:317–30; 1994.

    PubMed  CAS  Google Scholar 

  17. Ohlsson A, Lindgren J, Andersson S, Agurell S, Gillespie H and Hollister L. Single-dose kinetics of deuterium-labeled cannabidiol in man after smoking and intravenous administration. Biomed. Environ. Mass Spectrom. 13:77–83; 1986.

    Article  PubMed  CAS  Google Scholar 

  18. Cone E. Saliva testing for drugs of abuse. Ann. N. Y. Acad. Sci. 694:91–127; 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Niedbala R, Kardos K, Fritch D, Kardos S, Fries T, Waga J, Robb J and Cone E. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J. Anal. Toxicol. 25:289–303; 2001.

    PubMed  CAS  Google Scholar 

  20. Maseda C, Hama K, Fukui Y, Matsubara K, Takahashi S and Akane A. Detection of Δ9-THC in saliva by capillary GC/ECD after marihuana smoking. Forensic Sci. Int., 32:259–266; 1986.

    Article  PubMed  CAS  Google Scholar 

  21. Huestis M and Cone E. Relationship of delta-9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 28(6):394–399; 2004.

    PubMed  CAS  Google Scholar 

  22. Cook C, Jeffcoat A, Hill J, Pugh D, Patetta P, Sadler B, White W, Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S(+)methamphetamine hydrochloride. Drug. Metab. Dispos. 21:717–723; 1993.

    PubMed  CAS  Google Scholar 

  23. Cook C, Brine D, Jeffcoat A, Hill J, Wall M, Perez-Reyes M and DiGuiseppi S. Phencyclidine disposition after intravenous and oral doses. Clin. Pharmacol. Ther. 31:625–634; 1982.

    Article  PubMed  CAS  Google Scholar 

  24. McCarron M, Walberg C, Soares J, Gross S and Baselt R. Detection of phencyclindine usage by radioimmunoassay of saliva. J. Anal. Toxicol. 8:197–201; 1984.

    PubMed  CAS  Google Scholar 

  25. ONeal C, Crouch D, Rollins D and Fatah A. The effects of collection method on oral fluid codeine concentrations. J. Anal. Toxicol. 24:536–542; 2000.

    CAS  Google Scholar 

  26. Navarro M, Pichini S, Farre M, Ortuno J, Roset P, Segura J and de la Torre R. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin. Chem. 47:1788–1795; 2001.

    PubMed  CAS  Google Scholar 

  27. Samyn N and Van Haeren C. On-site testing of saliva and sweat with Drugwipe and determination of concentration of drugs of abuse in saliva, plasma and urine of suspected users. Int. J. Legal Med. 113:150–154; 2000.

    Article  PubMed  CAS  Google Scholar 

  28. Miles MV, Tennison MB, Greenwood RS. Intraindividual variability of carbamazepaine, phenobarbital and phenytoin concentrations in saliva. Ther. Drug Monit. 13:166–171; 1991.

    Article  PubMed  CAS  Google Scholar 

  29. Kintz P and Samyn N. Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther. Drug Monit. 24(2):239–246; 2002.

    Article  PubMed  CAS  Google Scholar 

  30. Kauert G. Drogennachweis im Speichel vs. Serum. Blutalkohol 37:76–83; 2000.

    Google Scholar 

  31. Kato K, Hillsgrove M, Weinhold L, Gorelick D, Darwin W and Cone E. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J. Anal. Toxicol. 17:338–341; 1993.

    PubMed  CAS  Google Scholar 

  32. Rana S, Moore C, Vincent M, Coulter C, Agrawal A and Soares J. Determination of propoxyphene in oral fluid. J. Anal. Toxicol. 30(8):516–518; 2006.

    PubMed  CAS  Google Scholar 

  33. Laloup M, Tilman G, Maes V, De Boeck G, Wallemacq P, Ramaekers J and Samyn N. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci. Int. 153(1):29–37; 2005.

    Article  PubMed  CAS  Google Scholar 

  34. Cooper G, Wilson L, Reid C, Baldwin D, Hand C and Spiehler V. Validation of an EIA microtiter plate assay for amphetamines in oral fluid. Forensic Sci. Int. 159 (2–3):104–112; 2006.

    Article  PubMed  CAS  Google Scholar 

  35. Barnes A, Kim I, Schepers R, Moolchan E, Wilson L, Cooper G, Reid C, Hand C and Huestis M. Sensitivity, specificity and efficiency in detecting opiate use in oral fluid with the Cozart™ opiate microplate EIA and GC/MS following controlled codeine administration. J. Anal. Toxicol. 27(7):402–406; 2003.

    PubMed  CAS  Google Scholar 

  36. Kim I, Barnes A, Schepers R, Oyler J, Moolchan E, Wilson L, Cooper G, Reid C, Hand C and Huestis M. Sensitivity, specificity and efficiency in detecting cocaine use in oral fluid with the Cozart cocaine metabolite microplate EIA and GC/MS at proposed screening and confirmation cutoffs. Clin. Chem. 49(9):1498–1503; 2003.

    Article  PubMed  CAS  Google Scholar 

  37. Cooper G, Wilson L, Reid C, Baldwin D, Hand C and Spiehler V. Analysis of cocaine and cocaine metabolites in oral fluid by Cozart microplate EIA and GC/MS. J. Anal. Toxicol. 28(6): 498–503; 2004.

    PubMed  CAS  Google Scholar 

  38. Cooper G, Wilson L, Reid C, Baldwin D, Hand C and Spiehler V. Comparison of GC/MS and EIA results for analysis of methadone in oral fluid. J. Forensic Sci. 150(4):928–932; 2005.

    Google Scholar 

  39. Allen K, Azad R, Field H and Blake D. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann. Clin. Biochem. 42(4):277–284; 2005.

    Article  PubMed  CAS  Google Scholar 

  40. Kintz P, Villain M, Concheiro M and Cirimele V. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS-MS. Forensic Sci. Int. 150(2–3):213–220; 2005.

    Article  PubMed  CAS  Google Scholar 

  41. Wylie F, Torrance H, Anderson R and Oliver J. Drugs in oral fluid. Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid. Forensic Sci. Int. 150 (2–3):191–198; 2005.

    Article  PubMed  CAS  Google Scholar 

  42. Verstraete A and Puddu M. Evaluation of different roadside drug tests. Rosita, Roadside Testing Assessment, Rosita Consortium, Gent, Belgium, 167–232; 2001.

    Google Scholar 

  43. De Giovanni N, Fucci N, Chiarotti M, Scarlata S. Cozart RapiScan system: our experience with saliva tests. J. Chromatogr. B 773(1):1–6; 2002.

    Article  Google Scholar 

  44. Kolbrich E, Kim I, Barnes A, Moolchan E, Wilson L, Cooper G, Reid C, Baldwin D, Hand C and Huestis M. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. J. Anal. Toxicol. 27(7):402–406; 2003.

    Google Scholar 

  45. Kacinko S, Barnes A, Kim I, Moolchan E, Wilson L, Cooper G, Reid C, Baldwin D, Hand C and Huestis M. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci. Int. 141(1):41–48; 2004.

    Article  PubMed  CAS  Google Scholar 

  46. Scheidweiler K and Huestis M. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J. Chromatogr. B 835(1–2):90–99; 2006.

    Article  CAS  Google Scholar 

  47. Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V and Samyn N. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager DrugTest. Forensic Sci. Int. 161(2–3):175–179; 2006.

    Google Scholar 

  48. Day D, Kuntz D, Feldman M and Presley L. Detection of THCA in oral fluid by GC-MS-MS. J. Anal. Toxicol. 30(9):645–650; 2006.

    PubMed  CAS  Google Scholar 

  49. Niedbala S, Kardos K, Fritch D, Kunsman K, Blum K, Newland G, Waga J, Kurtz L, Bronsgeest M and Cone E. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J. Anal. Toxicol. 29(7):607–615; 2005.

    PubMed  CAS  Google Scholar 

  50. Teixeira H, Proenca P, Castanheira A, Santos S, Lopez-Rivadulla M, Corte-Real F, Marques E and Vieira D. Cannabis and driving: the use of LC-MS to detect delta-9-tetrahydrocannabinol (delta-9-THC) in oral fluid samples. Forensic Sci. Int. 146 (Supp.):S61–63; 2004.

    Article  PubMed  CAS  Google Scholar 

  51. Niedbala S, Kardos K, Waga J, Fritch D, Yeager L, Doddamane S and Schoener E. Laboratory analysis of remotely collected oral fluid specimens for opiates by immunoassay. J. Anal. Toxicol. 25(5):310–315; 2001.

    PubMed  CAS  Google Scholar 

  52. Presley L, Lehrer M, Seiter W, Hahn D, Rowland B, Smith M, Kardos K, Fritch D, Salamone S, Niedbala R and Cone E. High prevalence of 6-acetylmorphine in morphine positive oral fluid specimens. Forensic Sci. Int. 133(1–2):22–25; 2003.

    Article  PubMed  CAS  Google Scholar 

  53. Moore C, Rana S, Coulter C, Feyerherm F and Prest H. Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair. J. Anal. Toxicol. 30(3):171–177; 2006.

    PubMed  CAS  Google Scholar 

  54. Wan S, Matin S and Azarnoff D. Kinetics, salivary excretion of amphetamine isomers and effect of urinary pH. Clin. Pharmacol Ther. 23:585–590; 1978.

    PubMed  CAS  Google Scholar 

  55. Schepers R, Oyler J, Joseph R Jr., Cone E, Moolchan E and Huestis M. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 49(1):121–132; 2003.

    Article  PubMed  CAS  Google Scholar 

  56. Samyn N, De Boeck G, Wood M, Lamers C, De Waard D, Brookhuis K, Verstraete A and Riedel W. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci. Int. 128(1–2):90–97; 2002.

    Article  PubMed  CAS  Google Scholar 

  57. Cooper G, Peters F, Maurer H and Hand C. Compliance of Individuals Prescribed Dexedrine™ through Determination of Amphetamine Isomer Ratios in Oral Fluid. Presented at the Society of Forensic Toxicologists Meeting, Dallas; 2004.

    Google Scholar 

  58. Kintz P. Excretion of MBDB and BDB in urine, saliva and sweat following single oral administration. J. Anal. Toxicol. 21:570–575; 1997.

    PubMed  CAS  Google Scholar 

  59. Suzuki S, Inoue T, Hori H and Inayama S. Analysis of methamphetamine in hair, nail, sweat and saliva by mass fragmentography. J. Anal. Toxicol. 13:176–178; 1989.

    PubMed  CAS  Google Scholar 

  60. Staub C. Chromatographic procedures for determination of cannabinoids in biological samples, with special attention to blood and alternative matrices like hair, saliva, sweat and meconium. J. Chromatogr. B 733(1–2):119–126; 1999.

    CAS  Google Scholar 

  61. Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M and Cone E. Passive cannabis smoke exposure and oral fluid testing. J. Anal. Toxicol. 28(7):546–552; 2004.

    PubMed  CAS  Google Scholar 

  62. Perez-Reyes M. Marijuana smoking: factors that influence te bioaviailbility of tetrahydrocannabinol. In CN Chiang and RL Hawks, Eds, Research Finding on Smoking of Abused Substances. NIDA Research Monograph 99. Rockville, MD:42–62; 1990.

    Google Scholar 

  63. Teixeira H, Procena P, Verstraete A, Corte-Real F and Vieira D. Analysis of delta9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. Forensic Sci. Int. 150(2–3):205–211; 2005.

    Article  PubMed  CAS  Google Scholar 

  64. Schramm W, Craig P, Smith R and Berger G. Cocaine and benzoylecgonine in saliva, serum and urine. Clin. Chem. 39:481–487; 1993.

    PubMed  CAS  Google Scholar 

  65. Cone E, Kumor K, Thompson L and Sherer M. Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J. Anal. Toxicol. 12:200–206; 1988.

    PubMed  CAS  Google Scholar 

  66. Cone E and Weddington W (1989). Prolonged occurrence of cocaine in human saliva and urine after chronic use. J. Anal. Toxicol. 13:65–68; 1989.

    Google Scholar 

  67. Cone E, Oyler J and Darwin W. Cocaine disposition in saliva following intravenous, intranasal and smoked administration. J. Anal. Toxicol. 21, 465–475; 1997.

    PubMed  Google Scholar 

  68. Jufer R, Wstadik A, Walsh S, Levine B and Cone J. Elimination of cocaine and metabolites in plasma, saliva and urine following repeated oral administration to human volunteers. J. Anal. Toxicol. 24:467–477; 2000.

    PubMed  CAS  Google Scholar 

  69. Moolchan E, Cone E, Wstadik A, Huestis M and Preston K. Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. J. Anal. Toxicol. 24:458–466; 2000.

    PubMed  CAS  Google Scholar 

  70. Gorodetzky C and Kullberg M. Validity of screening methods for drugs of abuse in biological fluids. II. Heroin in plasma and saliva. Clin. Pharmacol. Ther. 15: 570–587; 1974.

    Google Scholar 

  71. Cone E. Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine and beard compared to drug induced effects on pupils and behavior. J. Anal. Toxicol. 14:1–7; 1990.

    PubMed  CAS  Google Scholar 

  72. Cooper G, Wilson L, Reid C, Baldwin D, Hand C and Spiehler V. Analysis of opiates in oral fluid by Cozart microplate EIA and GC/MS. Forensic Sci. Int. 154 (2–3):240–246; 2005.

    Article  PubMed  CAS  Google Scholar 

  73. Moore L, Wicks J, Spiehler V and Holgate R. Gas chromatography /mass spectrometry confirmation of Cozart Rapiscan saliva methadone and opiates tests. J. Anal. Toxicol. 25:520–524; 2001.

    PubMed  CAS  Google Scholar 

  74. Crouch D. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci. Int. 150(2–3):165–173; 2005.

    Article  PubMed  CAS  Google Scholar 

  75. Dickinson S, Park A, Nolan S, Kenworthy S, Nicholson C, Midgley J, Pinfold R and Hampton S. The recovery of illicit drugs from oral fluid sampling devices. Forensic Sci. Int. 165(1):78–84; 2007.

    Article  CAS  Google Scholar 

  76. Jehanli A, Brannan S, Moore L, and Spiehler VR. Blind trials of an onsite saliva drug test. J. Forensic Sci. 46(5): 1214–1220; 2001.

    PubMed  CAS  Google Scholar 

  77. Clarke J and Wilson J. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci. Int. 150:161–164; 2005.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Vina Spiehler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gail Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lake County Crime Laboratory, Painesville, OH

    Amanda J. Jenkins

  2. National Scientific Services, Baltimore, MD

    Yale H. Caplan

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press

About this chapter

Cite this chapter

Spiehler, V., Cooper, G. (2008). Drugs-of-Abuse Testing in Saliva or Oral Fluid. In: Jenkins, A.J., Caplan, Y.H. (eds) Drug Testing in Alternate Biological Specimens. Forensic Science And Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-318-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-318-9_5

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-709-9

  • Online ISBN: 978-1-59745-318-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation